These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38246777)

  • 21. [Comprehensive management guideline for breast cancer follow-up and concomitant diseases].
    Ma F; Xu BH; Shao ZM;
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):29-41. PubMed ID: 30678414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Update points for the 2022 edition of the European Association for the Study of Liver Diseases Clinical Practice Guidelines for the Management of Hepatic Encephalopathy and comparison with China's 2018 edition guidelines].
    Zhang TY; Sun X; Yao YH; Jin Q; Gan DN; Ye YA; Li XK
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):921-927. PubMed ID: 37872087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China.
    Di J; Rutherford S; Wu J; Song B; Ma L; Chen J; Chu C
    PLoS One; 2015; 10(12):e0144819. PubMed ID: 26657110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial pattern of China's rural digital economy based on subjective-Objective evaluation: Evidence from 2085 counties.
    Liu X; Ma F; Guo T; Ding Z
    PLoS One; 2024; 19(2):e0292249. PubMed ID: 38381735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive assessment of resources for prevention and control of chronic and non-communicable diseases in China: a cross-sectional study.
    Yi Z; Xu T; Yang J; Yu S; Zhou M; Li H; Guo J; Qian J; Dong W
    BMJ Open; 2023 Jul; 13(7):e071407. PubMed ID: 37474175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Hybrid' top down bottom up health system innovation in rural China: A qualitative analysis.
    Klundert JV; de Korne D; Yuan S; Wang F; van Wijngaarden J
    PLoS One; 2020; 15(10):e0239307. PubMed ID: 33027287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Availability of Mammography Services at Federally Qualified Health Centers Associated with Breast Cancer Mortality-to-Incidence Ratios? An Ecological Analysis.
    Adams SA; Choi SK; Eberth JM; Friedman DB; Yip MP; Tucker-Seeley RD; Wigfall LT; Hébert JR
    J Womens Health (Larchmt); 2015 Nov; 24(11):916-23. PubMed ID: 26208105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 30. Geographical patterns of fertility decline in Guangdong: China's population policy through the censuses of 1982 and 1990.
    Akkerman A; He JS
    Can Geogr; 1998; 42(2):174-92. PubMed ID: 12294815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the Distribution and Convergence of County-level Healthcare Resources Allocative Efficiency in China Based on DEA and Spatial Panel Model.
    Sun J; Sun Z; Yang C; Shen Y
    Inquiry; 2023; 60():469580231178122. PubMed ID: 37300427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):457-490. PubMed ID: 35754224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [China faces a challenge of breast cancer prevention and control].
    Zhang BN; Chen WQ; Zhang X; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):798-800. PubMed ID: 27784469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. China's urban transition.
    Pannell C
    J Geog; 1995; 94(3):394-403. PubMed ID: 12178548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact and clinical value of the revised 2019 Chinese HER-2 testing guidelines on the detect result evaluation of invasive breast cancer cases with equivocal HER-2 immunostaining by using fluorescence in situ hybridization].
    Zhang L; Wang WW; Jiang GZ; Zhang YP
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):833-837. PubMed ID: 34407587
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement and identification of relative poverty level of pastoral areas: an analysis based on spatial layout.
    Lin H; Gao Y; Zhu T; Wu H; Hou P; Li W; Hou S; Arshad MU
    Environ Sci Pollut Res Int; 2022 Dec; 29(58):87157-87169. PubMed ID: 35802323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
    Xu B; Hu X; Feng J; Geng C; Jin F; Li H; Li M; Li Q; Liao N; Liu D; Liu J; Liu Q; Lu J; Liu Z; Ma F; Ouyang Q; Pan Y; Shen K; Sun T; Teng Y; Tong Z; Wang B; Wang H; Wang S; Wang S; Wang T; Wang X; Wang X; Wang Y; Wang Z; Wu J; Yan M; Yang J; Yin Y; Yuan P; Zhang J; Zhang P; Zhang Q; Zheng H
    Cancer; 2020 Aug; 126 Suppl 16():3867-3882. PubMed ID: 32710660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.